Does ROMIDEPSIN Cause Disease progression? 43 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Disease progression have been filed in association with ROMIDEPSIN (Romidepsin). This represents 3.4% of all adverse event reports for ROMIDEPSIN.
43
Reports of Disease progression with ROMIDEPSIN
3.4%
of all ROMIDEPSIN reports
16
Deaths
5
Hospitalizations
How Dangerous Is Disease progression From ROMIDEPSIN?
Of the 43 reports, 16 (37.2%) resulted in death, 5 (11.6%) required hospitalization, and 1 (2.3%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
Yes, Disease progression is listed as a known adverse reaction in the official FDA drug label for ROMIDEPSIN.
What Other Side Effects Does ROMIDEPSIN Cause?
Peripheral t-cell lymphoma unspecified (102)
Nausea (91)
Death (90)
Thrombocytopenia (90)
Pyrexia (77)
Drug ineffective (69)
Anaemia (61)
Electrocardiogram qt prolonged (61)
Platelet count decreased (60)
Vomiting (57)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which ROMIDEPSIN Alternatives Have Lower Disease progression Risk?
ROMIDEPSIN vs ROMIPLOSTIM
ROMIDEPSIN vs ROMOSOZUMAB
ROMIDEPSIN vs ROMOSOZUMAB-AQQG
ROMIDEPSIN vs ROPEGINTERFERON ALFA-2B-NJFT
ROMIDEPSIN vs ROPINIROLE